Delivery Order 36C25522D0055-36C25524N0317
Award Date 9/1/24
Potential Completion Date 8/31/27
Potential Value $195K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Sterling, VA, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Sofie CO., operating as IBA Molecular, received a delivery order award valued at $339.6K on January 22, 2026, for radioactive isotopes and positron emission tomography (PET) tracers supporting the Michael E. DeBakey VA Medical Center in Sterling, Virginia. This delivery order, with an ultimate completion date of February 28, 2027, is structured as a firm fixed-price contract with no set-aside designation. The award is issued under a larger indefinite delivery vehicle with VA Veterans...
- Sofie CO., doing business as IBA Molecular, was awarded a $992,398 delivery order by Veterans Integrated Service Network (VISN) 15, a component of the Department of Veterans Affairs, on June 1, 2024. The award is designated as a total small business set-aside and calls for the supply of PYLARIFY (piflufolastat F-18), a positron emission tomography (PET) imaging agent used for prostate cancer detection. Performance will be completed at the VA Saint Louis Health Care System in St. Louis, Missouri,...
- The U.S. Department of Veterans Affairs, through Veterans Integrated Service Network 4, awarded a $1.39 million firm fixed-price purchase order to Sofie CO. (doing business as IBA Molecular) on May 1, 2024, for the supply of FDG (fluorodeoxyglucose) and NEURACEQ (florbetaben F-18) radiopharmaceuticals. These PET (positron emission tomography) imaging agents are critical diagnostic tools used for oncology imaging and Alzheimer's disease detection, respectively, supporting the VA's medical imaging...
- Sofie CO., doing business as IBA Molecular, was awarded a $5.96 million firm fixed-price purchase order by Veterans Integrated Service Network 19 (VA VISN 19) on October 1, 2023, for the supply of positron emission tomography/computed tomography (PET/CT) radiopharmaceuticals through September 30, 2028. The contract was executed without set-aside designation and covers routine delivery of specialized imaging agents to support VA medical facilities, including F-18 fluorodeoxyglucose (FDG), F-18...
- Sofie CO., doing business as IBA Molecular, was awarded a $241,784.24 firm fixed-price purchase order by the Department of Veterans Affairs' Veterans Integrated Service Network 5 on August 1, 2023, for delivery of PYLARIFY (piflufolastat F-18), a radioactive pharmaceutical used in positron emission tomography imaging for prostate cancer detection. The contract is designated as a total small business set-aside and specifies performance in Sterling, Virginia, with an ultimate completion date of...
- Sofie CO., operating as IBA Molecular and headquartered in Sterling, Virginia, was awarded a $1.12 million firm fixed-price delivery order on April 15, 2025, to supply positron emission tomography (PET) radiopharmaceuticals to the Buffalo VA Medical Center through the Department of Veterans Affairs' Veterans Integrated Service Network 2. This delivery order, with an ultimate completion date of April 14, 2026, is issued under a larger $1.93 million indefinite delivery vehicle established in April...
- The Department of Veterans Affairs, Veterans Integrated Service Network 16 (VISN 16), awarded a $211,476.72 firm fixed-price purchase order to Sofie CO. (doing business as IBA Molecular) on October 1, 2023, for emergency isotopes with a completion date of December 31, 2023. The award carries no set-aside designation and is for performance at the contractor's Sterling, Virginia facility. Sofie CO., a for-profit subsidiary of Sofie Biosciences, Inc., specializes in the development, production, and...
- This is a federal contract award from the Department of Veterans Affairs (VA) to Sofie CO., doing business as Sofie, a subsidiary of Sofie Biosciences, Inc. The contract is for the delivery of PET radiopharmaceuticals, which are specialized imaging agents used for medical diagnostics and cancer treatment. The award, valued at $188,258.00, is a delivery order under a larger $5.86 million Indefinite Delivery Vehicle (IDV) contract with the VA's Veterans Integrated Service Network (VISN) 15 for the...
- The Department of Veterans Affairs Veterans Integrated Service Network 4 awarded a $1.88M firm fixed-price purchase order to Sofie CO. (doing business as IBA Molecular) on June 30, 2022, for F-18 radiopharmacy services through June 30, 2024. Sofie CO., a subsidiary of Sofie Biosciences, Inc. headquartered in Sterling, Virginia, is a specialized manufacturer and supplier of molecular diagnostics and therapeutic radiopharmaceuticals. The contract carries no set-aside designation and reflects...
- The Defense Health Agency awarded Sofie CO. (doing business as IBA Molecular) a $10,826.16 firm fixed-price call under a blanket purchase agreement for radiopharmaceutical supply supporting prostate cancer patient diagnostics. The contract, effective through September 30, 2026, represents a task order for specialized molecular imaging agents to support military medical treatment facilities. This award carries no set-aside designation and reflects Sofie CO.'s established position as a specialized...